Ziyad Al-Aly, MD, and weight loss drugs (IMAGE)
Caption
“Our approach has allowed us to build a comprehensive atlas mapping the associations of GLP-1RA spanning all organ systems,” said the study’s senior author, Ziyad Al-Aly, MD, a clinical epidemiologist and nephrologist at WashU Medicine. “The study’s results provide insights into some known and previously unrecognized benefits and risks of GLP-1RA that may be useful to inform clinical care and guide research agendas.”
Credit
Matt Miller/WashU Medicine
Usage Restrictions
Please credit Matt Miller/WashU Medicine
License
Original content